233 related articles for article (PubMed ID: 37753338)
1. How does NFAT3 regulate the occurrence of cardiac hypertrophy?
Hui W; Wenhua S; Shuojie Z; Lulin W; Panpan Z; Tongtong Z; Xiaoli X; Juhua D
Int J Cardiol Heart Vasc; 2023 Oct; 48():101271. PubMed ID: 37753338
[TBL] [Abstract][Full Text] [Related]
2. NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.
Zhang X; Lei F; Wang XM; Deng KQ; Ji YX; Zhang Y; Li H; Zhang XD; Lu Z; Zhang P
J Am Heart Assoc; 2020 Aug; 9(16):e016419. PubMed ID: 32805187
[TBL] [Abstract][Full Text] [Related]
3. Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor.
Tu VC; Sun H; Bowden GT; Chen QM
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1248-55. PubMed ID: 17108007
[TBL] [Abstract][Full Text] [Related]
4. The function of LncRNA-H19 in cardiac hypertrophy.
Su W; Huo Q; Wu H; Wang L; Ding X; Liang L; Zhou L; Zhao Y; Dan J; Zhang H
Cell Biosci; 2021 Aug; 11(1):153. PubMed ID: 34344446
[TBL] [Abstract][Full Text] [Related]
5. Opposing roles of FoxP1 and Nfat3 in transcriptional control of cardiomyocyte hypertrophy.
Bai S; Kerppola TK
Mol Cell Biol; 2011 Jul; 31(14):3068-80. PubMed ID: 21606195
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic receptor blockade-induced regression of pressure-overload cardiac hypertrophy is associated with inhibition of the calcineurin/NFAT3/GATA4 pathway.
Yang D; Ma S; Tan Y; Li D; Tang B; Chen J; Su X; Li G; Zhang X; Yang Y
Mol Med Rep; 2010; 3(3):497-501. PubMed ID: 21472269
[TBL] [Abstract][Full Text] [Related]
7. Capillary electrophoretic mobility shift assay for binding of DNA with NFAT3, a transcription factor from H9c2 cardiac myoblast cells.
Park SH; Ban E; Song EJ; Lee H; Chung DS; Yoo YS
Electrophoresis; 2011 Aug; 32(16):2174-80. PubMed ID: 21792994
[TBL] [Abstract][Full Text] [Related]
8. Ras regulates NFAT3 activity in cardiac myocytes.
Ichida M; Finkel T
J Biol Chem; 2001 Feb; 276(5):3524-30. PubMed ID: 11044444
[TBL] [Abstract][Full Text] [Related]
9. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
[TBL] [Abstract][Full Text] [Related]
10. [CaN-NFAT3 signal pathway: a crucial hinge relates Ca2+ signal with cardiomyocyte hypertrophy].
Zhu SJ; Yang YJ; Yu LJ; Huang L
Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):19-21. PubMed ID: 14990015
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells.
Ouyang W; Hu Y; Li J; Ding M; Lu Y; Zhang D; Yan Y; Song L; Qu Q; Desai D; Amin S; Huang C
Carcinogenesis; 2007 Oct; 28(10):2218-26. PubMed ID: 17522069
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer.
Xiao T; Zhu JJ; Huang S; Peng C; He S; Du J; Hong R; Chen X; Bode AM; Jiang W; Dong Z; Zheng D
Oncogene; 2017 May; 36(20):2835-2845. PubMed ID: 27893713
[TBL] [Abstract][Full Text] [Related]
13. Activation of a nuclear factor of activated T-lymphocyte-3 (NFAT3) by oxidative stress in carboplatin-mediated renal apoptosis.
Lin H; Sue YM; Chou Y; Cheng CF; Chang CC; Li HF; Chen CC; Juan SH
Br J Pharmacol; 2010 Dec; 161(7):1661-76. PubMed ID: 20718735
[TBL] [Abstract][Full Text] [Related]
14. Calreticulin silencing inhibits extracellular matrix synthesis of human gingival fibroblasts cultured on three-dimensional poly(lactic-co-glycolic acid) scaffolds by inhibiting the calcineurin/nuclear factor of activated T cells 3 signalling pathway.
Wei H; Chen Z; Zheng Y; Chen Q; Min H; Ma Q; Gao B; Mo S
Ann Anat; 2022 Jan; 239():151820. PubMed ID: 34411706
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of NFAT3 blocked TPA-induced COX-2 and iNOS expression, and enhanced cell transformation in Cl41 cells.
Li J; Song L; Zhang D; Wei L; Huang C
J Cell Biochem; 2006 Nov; 99(4):1010-20. PubMed ID: 16475165
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of BACE1 by NFAT3 leads to enhanced amyloidogenic processing.
Mei Z; Yan P; Tan X; Zheng S; Situ B
Neurochem Res; 2015 Apr; 40(4):829-36. PubMed ID: 25663301
[TBL] [Abstract][Full Text] [Related]
17. Regulation of inward rectifier potassium current ionic channel remodeling by AT
He J; Xu Y; Yang L; Xia G; Deng N; Yang Y; Tian Y; Fu Z; Huang Y
Cell Biol Int; 2018 Sep; 42(9):1149-1159. PubMed ID: 29719087
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation.
Yao K; Cho YY; Bergen HR; Madden BJ; Choi BY; Ma WY; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(18):8725-35. PubMed ID: 17875713
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
20. Effects of Sodium Ferulate on Cardiac Hypertrophy Are
Chen P; Wen Z; Shi W; Li Z; Chen X; Gao Y; Xu S; Gong Q; Deng J
Front Pharmacol; 2021; 12():674570. PubMed ID: 34690749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
